Nitric oxide synthases and cyclophosphamide-induced cystitis in rats

Area of Science:

• Pharmacology
• Urology
• Inflammation Research

Background:

• Cyclophosphamide (CYP) is a chemotherapeutic agent known to induce cystitis, a condition characterized by bladder inflammation.
• Nitric oxide (NO) and tachykinin NK1 receptors are implicated in inflammatory processes, but their specific roles in CYP-induced cystitis are not fully elucidated.

Purpose of the Study:

• To investigate the roles of inducible nitric oxide synthase (iNOS), neuronal nitric oxide synthase (nNOS), and NK1 receptors in the pathogenesis of CYP-induced cystitis in rats.
• To evaluate the therapeutic potential of inhibiting iNOS, nNOS, and NK1 receptors in this cystitis model.

Main Methods:

• Rats were treated with cyclophosphamide (CYP) to induce cystitis.
• The effects of specific inhibitors of iNOS (S-methylthiourea, MITU) and nNOS (7-nitroindazole, 7-NI), as well as an NK1 receptor antagonist (WIN 51,708), were assessed.
• Key parameters measured included bladder-protein plasma extravasation (PPE), urinary NO metabolites, and histological changes.

Main Results:

• CYP induced significant increases in bladder PPE, urinary NO metabolites, and histological signs of inflammation.
• iNOS inhibition with MITU markedly reduced CYP-induced PPE (>90%) and improved histological damage.
• nNOS inhibition with 7-NI had no significant effect on PPE or histology.
• NK1 receptor antagonism with WIN 51,708 reduced PPE and inflammation, but to a lesser extent than iNOS inhibition.
• Combined iNOS and NK1 receptor inhibition offered no additional benefit over iNOS inhibition alone.

Conclusions:

• NO, primarily generated by iNOS, plays a critical role in the development of CYP-induced cystitis.
• iNOS is the main contributor to the inflammatory response, whereas nNOS is not significantly involved.
• NK1 receptor activation may contribute to NO production and inflammation, but iNOS inhibition is the most effective therapeutic strategy.